Problems with Podocytes and Platelets: Minimal Change Disease (MCD) and Acquired Amegakaryocytic Thrombocytopenia (AAMT) (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0730; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Eltrombopag and cyclosporine started with symptomatic improvement; except persistent bleeding required stem cell transplant. The divergent response between the conditions may stem from the anti-TPO antibodies shielding the TPO receptor agonist. Take-Away: Expand the Differential: In nephrotic syndrome with cytopenias consider bone marrow biopsy The Hypoproliferative Signal: Macrocytosis and absent megakaryocytes distinguish AAMT from ITP/TMA Anticipate Resistance: Immune dysregulation may require combined T- and B-cell targeting or hematopoietic stem cell transplant"
Bone Marrow Transplantation • Glomerulonephritis • Infectious Disease • Nephrology • Renal Disease • Respiratory Diseases • Thrombocytopenia • Tuberculosis • CD8 • IL13 • ITGB3
|
|
Neil Asn Evans; Harpreet Kaur; Rajib K. Gupta; Nasim Wiegley; Shubha Ananthakrishnan; Niti Madan
|